Next Article in Journal
Effect of Collagen Hydrolysates from Silver Carp Skin (Hypophthalmichthys molitrix) on Osteoporosis in Chronologically Aged Mice: Increasing Bone Remodeling
Next Article in Special Issue
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus
Previous Article in Journal
Effect of Educational Interventions on Understanding and Use of Nutrition Labels: A Systematic Review
Article Menu

Export Article

Open AccessArticle
Nutrients 2018, 10(10), 1433; https://doi.org/10.3390/nu10101433

Evaluation of A Concentrated Preterm Formula as a Liquid Human Milk Fortifier in Preterm Babies at Increased Risk of Feed Intolerance

1
Neonatal-Perinatal Medicine, British Columbia Women’s and Children’s Hospital, University of British Columbia, Vancouver, BC V6H 3N1, Canada
2
Department of Pediatrics, University of British Columbia, Vancouver, BC V5Z 3V4 Canada
3
British Columbia Children’s Hospital Research Institute (BCCHRI), Vancouver, BC V5Z 4H4 Canada
4
School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3 Canada
Deceased on 10 February 2016.
*
Author to whom correspondence should be addressed.
Received: 28 August 2018 / Revised: 29 September 2018 / Accepted: 2 October 2018 / Published: 4 October 2018
(This article belongs to the Special Issue Lactose Intolerance Update)
Full-Text   |   PDF [776 KB, uploaded 4 October 2018]   |  

Abstract

There are concerns around safety and tolerance of powder human milk fortifiers to optimize nutrition in preterm infants. The purpose of this study was to evaluate the tolerance and safety of a concentrated preterm formula (CPF) as a liquid human milk fortifier (HMF) for premature infants at increased risk of feeding intolerance. We prospectively enrolled preterm infants over an 18-month period, for whom a clinical decision had been made to add CPF to human milk due to concerns regarding tolerance of powder HMF. Data on feed tolerance, anthropometry, and serum biochemistry values were recorded. Serious adverse events, such as mortality, necrotizing enterocolitis (NEC), and sepsis, were monitored. A total of 29 babies received CPF fortified milk during the study period. The most common indication for starting CPF was previous intolerance to powder HMF. Feeding intolerance was noted in 4 infants on CPF. The growth velocity of infants was satisfactory (15.9 g/kg/day) after addition of CPF to feeds. The use of CPF as a fortifier in preterm babies considered at increased risk for feed intolerance seems well tolerated and facilitates adequate growth. Under close nutrition monitoring, this provides an additional option for human milk fortification in this challenging subgroup of preterm babies, especially in settings with limited human milk fortifier options. View Full-Text
Keywords: premature; formula; fortification; human milk premature; formula; fortification; human milk
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Pillai, A.; Albersheim, S.; Matheson, J.; Lalari, V.; Wei, S.; Innis, S.M.; Elango, R. Evaluation of A Concentrated Preterm Formula as a Liquid Human Milk Fortifier in Preterm Babies at Increased Risk of Feed Intolerance. Nutrients 2018, 10, 1433.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top